Pro-Dex, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Pro-Dex, Inc.'s yearly results (2023–2026), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Profit Cash Ratio: Over the last 3 years, every $100 of reported profit came with $48 of operating cash. Lower than 94% of Healthcare companies in United States.
- Cash Locked Ratio: For every $100 of sales, $50 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $51 tied up three years earlier. More money tied up than 93% of Healthcare companies in United States.
- Steadiness Ratio: Sales grew in 3 of the last 3 years; profit grew in 2 of 3. Steadier than 85% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Jun 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
$48Over the last 3 years, every $100 of reported profit came with $48 of operating cash.
Lower than 94% of Healthcare companies in United States.
Self-Funding Ratio
4.3×Over the last 3 years its own operating cash covered its investment spending (capex) 4.3 times.
Higher than 84% of Healthcare companies in United States.
Cash Locked Ratio
$50For every $100 of sales, $50 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $51 tied up three years earlier.
More money tied up than 93% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 85% of Healthcare companies in United States.
Growth Efficiency Ratio
$21Sales grew 68% in 3 years; of every extra $100 of sales, $21 became extra profit.
Higher than 52% of Healthcare companies in United States.
Asset Productivity Ratio
+68% / +44%In 3 years sales changed by +68% while total assets changed by +44%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
1.7×Debt due within a year is covered 1.7 times by its yearly operating cash.
Higher than 73% of Healthcare companies in United States.
Cash Cushion Ratio
−5%Debt, after subtracting cash, equals 5% of its market value (net debt).
Lower than 74% of Healthcare companies in United States.
Tangible Assets Ratio
90%Of every $100 the company owns, $90 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 62% of Healthcare companies in United States.
Tangible Net Worth Ratio
85%Of every $100 of net worth, $85 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 66% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Pro-Dex, Inc. owes $0.36 for every $1 it owns. Net profit rose 52% in the year to Jun 2026, and grew 25% a year on average over 3 years.
Compared with Healthcare companies in United States · latest annual results Jun 2026.
P/E ratio
15.1Investors pay $15.1 for every $1 of Pro-Dex, Inc.'s yearly profit, lower than 74% of Healthcare companies in United States.
P/B ratio
4.22The share price is 4.22 times Pro-Dex, Inc.'s book value per share, higher than 68% of Healthcare companies in United States.
Market cap
$201 MThe total market value of all of Pro-Dex, Inc.'s shares at today's price (share price × number of shares), smaller than 58% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$48 MWhat Pro-Dex, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$14.73Net worth divided by the number of shares. The share price of $62.22 is 4.2 times this, which is the P/B above.
Return on equity (ROE)
32.4%Pro-Dex, Inc. earned 32.4% on its shareholders' money over the last year, higher than 94% of Healthcare companies in United States.
Owes vs Owns
0.36×Pro-Dex, Inc. owes $0.36 for every $1 it owns (low), lower than 54% of Healthcare companies in United States.
Dividend yield
NonePro-Dex, Inc. does not currently pay a dividend.
Revenue growth
+16%Revenue rose 16% in the year to Jun 2026, and grew 19% a year on average over 3 years.
Profit growth
+52%Net profit rose 52% in the year to Jun 2026, and grew 25% a year on average over 3 years.
Profit margin
17.6%Pro-Dex, Inc. keeps $18 of every $100 of revenue as net profit.
Cash quality
0.5×Cash from Pro-Dex, Inc.'s business was 0.5× its reported profit in the year to Jun 2026 — less cash came in than the profit reported.
Interest cover
16.0×Pro-Dex, Inc.'s operating profit covered its interest costs 16.0 times in the year to Jun 2026.
Cash vs debt
Net debtPro-Dex, Inc. had $10 M more debt than cash (net debt) at Jun 2026.
Questions
What is Pro-Dex, Inc.'s P/E ratio?
Investors pay $15.1 for every $1 of Pro-Dex, Inc.'s yearly profit, lower than 74% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Pro-Dex, Inc.: $201 M ÷ $48 M (30 Jun 2026) = 4.2.
What is Pro-Dex, Inc.'s return on equity?
Pro-Dex, Inc. earned 32.4% on its shareholders' money over the last year, higher than 94% of Healthcare companies in United States.
How much does Pro-Dex, Inc. owe compared with what it owns?
Pro-Dex, Inc. owes $0.36 for every $1 it owns (low), lower than 54% of Healthcare companies in United States.
Does Pro-Dex, Inc. pay a dividend?
No. Pro-Dex, Inc. does not currently pay a dividend.
Is Pro-Dex, Inc.'s revenue growing?
Revenue rose 16% in the year to Jun 2026, and grew 19% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.